Epidemiology of Pertussis in an Urban Region of Poland: Time for a Booster for Adolescents and Adults

  • Aneta Nitsch-Osuch
  • Ernest Kuchar
  • Grazyna Modrzejewska
  • Iwona Pirogowicz
  • Katarzyna Zycinska
  • Kazimierz Wardyn
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 755)


Since the last decades, an increase of reported incidence of pertussis has been observed in many countries, including Poland, despite high vaccination coverage among infants and children. Before the vaccinations era, pertussis was a major cause of morbidity and mortality among infants and young children. Currently, pertussis is increasingly reported in adolescents and adults. The objective of this paper was to present the epidemiology of pertussis in Mazovian region in Poland in years 2005–2009. In this report we analyzed retrospectively the epidemiological data collected by the Sanitary Station in Warsaw, Poland. A total of 1,455 cases of pertussis were reported in the Mazovian region of Poland in the years 2005–2009. The incidence of pertussis ranged from 2.4/100,000 (2006) to 7.9/100,000 (2008). The incidence was the highest in two groups: infants (>1 year of age; from 13.3/100,000 in 2005 to 32.7/100,000 in 2007) and teenagers (age of 10–14 years; from 11.8/100,000 in 2006 to 68.5/100,000 in 2008). The highest proportion of cases was also reported in the 10–14 years age-group (from 26.4% in 2009 to 46.0% in 2008). The number of hospitalizations due to pertussis ranged from 137 (2005) to 46 (2006), while the percentage of cases requiring hospitalization ranged from 37% (2005) to 25% (2007 and 2008). Three hundred ninety two (27%) cases of pertussis were reported among patients with negative or not confirmed history of pertussis vaccination. We conclude that there is an urgent need for booster vaccination against pertussis in adolescents and adults in Poland.


Booster Epidemiology Infection incidence Pertussis Vaccination 


  1. ACIP. (2006). Recommendations of the advisory committee on immunization practices and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Morbidity and Mortality Weekly Report, 55, 1–33.Google Scholar
  2. Bisgard, K. M., Pascual, F. B., Ehresmann, K. R., Miller, C. A., Cianfrini, C., Jennings, C. E., Rebmann, C. A., Gabel, J., Schauer, S. L., & Lett, S. M. (2004). Infant pertussis: Who was the source? Pediatric Infectious Disease, 23, 985–989.CrossRefGoogle Scholar
  3. Blandiardi, F., & Ferrera, G. (2009). Reducing the risk of pertussis in newborn infants. American Journal of Preventive Medicine, 50, 206–216.Google Scholar
  4. CDC (Centres for Disease Control and Prevention). (2005). QuickStats: Rate of hospitalizations for pertussis among infants aged <6 months – United States, 1994–1998 and 1999–2003. Morbidity and Mortality Weekly Report, 54, 1027.Google Scholar
  5. Cherry, J. D. (2005). The epidemiology of pertussis: A comparison of the epidemiology of Bordetella pertussis infection. Pediatrics, 115, 1422–1427.PubMedCrossRefGoogle Scholar
  6. Cherry, J. D. (2006). Epidemiology of pertussis. Pediatric Infectious Disease, 25, 351–362.Google Scholar
  7. Cherry, J. D. (2010). The present and future of control of pertussis. Clinical Infectious Diseases, 51, 663–667.PubMedCrossRefGoogle Scholar
  8. Committee on Infectious Diseases. (2006). Prevention of pertussis among adolescents: Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics, 117, 965–978.CrossRefGoogle Scholar
  9. Crowcroft, N. S., Booy, R., Harrison, T., Spicer, L., Britto, J., Mok, Q., Heath, P., Murdoch, I., Zambon, M., George, R., & Miller, E. (2003). Severe and unrecognized: Pertussis in UK infants. Archives of Disease in Childhood, 88, 802–806.PubMedCrossRefGoogle Scholar
  10. de Greeff, S. C., Mooi, F. R., Schellekens, J. F., & de Melker, H. E. (2008). Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. The Pediatric Infectious Disease Journal, 27, 218–223.PubMedCrossRefGoogle Scholar
  11. de Melker, H. E., Schellekens, J. F., Neppelenbroek, S. E., Mooi, F. R., Rumke, H. C., & Conyn-van Spaendonck, M. A. (2000). Re-emergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerging Infectious Diseases, 6, 348–357.PubMedCrossRefGoogle Scholar
  12. EUVAC NET data. www.euvac.net/graphics/euvac/pdf/pertussis. Accessed 22 Apr 2011.
  13. Galanis, E., King, A. S., Varughese, P., & Halperin, S. A. (2006). IMPACT investigations. Changing epidemiology and emerging risk groups for pertussis. Canadian Medical Association Journal, 174, 451–452.PubMedCrossRefGoogle Scholar
  14. Gurtis, D., Strebel, P. M., Bardenheier, B., Brennan, M., Tachdjian, R., Finch, E., Wharton, M., & Livengood, J. R. (1999). Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990–1996. Clinical Infectious Diseases, 28, 1230–1237.CrossRefGoogle Scholar
  15. Halasa, N. B., Barr, F. E., Johnson, J. E., & Edwards, K. M. (2003). Fatal pulmonary hypertension associated with pertussis in infants: Does extracorporeal membrane oxygenation have a role? Pediatrics, 112, 1274–1278.PubMedCrossRefGoogle Scholar
  16. He, Q., & Mertsola, J. (2008). Factors contributing to pertussis resurgence. Future Microbiology, 3, 329–339.PubMedCrossRefGoogle Scholar
  17. Hellenbrand, W., Beier, D., Jensen, E., Littmann, M., Meyer, C., Oppermann, H., Wirsing von Konig, C. H., & Reiter, S. (2009). The epidemiology of pertussis in Germany: Past and present. BMC Infectious Diseases, 9, 22–26.PubMedCrossRefGoogle Scholar
  18. Hewlett, E. L., & Edwards, K. M. (2005). Pertussis – Not just for kids. The New England Journal of Medicine, 352, 1215–1222.PubMedCrossRefGoogle Scholar
  19. Kowalzik, F., Barbosa, A. P., Fernandes, V. R., Carvalho, P. R., Avila-Aguero, M. L., Goh, D. Y., Goh, A., de Miguel, J. G., Moraga, F., Roca, J., Campins, M., Huang, M., Quian, J., Riley, N., Beck, D., & Verstraeten, T. (2007). Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatric Infectious Disease, 26, 238–242.CrossRefGoogle Scholar
  20. Lasserre, A., Laurent, E., Turbelin, C., Hanslik, T., Blanchon, T., & Guiso, N. (2011). Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area France May 2008 to March 2009. Eurosurveillance, 16, pii: 19783.Google Scholar
  21. Mertens, P. L., Stals, F. S., Schellekens, J. F., Houben, A. W., & Huisman, J. (1999). An epidemic of pertussis among elderly people in religious institution in The Netherlands. European Journal of Clinical Microbiology & Infectious Diseases, 18, 242–247.CrossRefGoogle Scholar
  22. Mooi, F. R. (2010). Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen. Infection, Genetics and Evolution, 10, 36–49.PubMedCrossRefGoogle Scholar
  23. Mooi, F. R., van Loo, I. H., van Gent, M., He, Q., Bart, M. J., Heuvelman, K. J., de Greeff, S. C., Diavatopoulos, D., Teunis, P., Nagelkerke, N., & Mertsola, J. (2009). Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerging Infectious Diseases, 15, 1206–1213.PubMedCrossRefGoogle Scholar
  24. National Institute of Public Health. (2005). Infectious diseases and poisonings in Poland. Annual Report Year 2005. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/epimeld/2005/Ch_2005. Accessed 25 Apr 2011.
  25. National Institute of Public Health. (2006). Infectious diseases and poisonings in Poland. Annual Report Year 2006. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/epimeld/2006/Ch_2006. Accessed 25 Apr 2011.
  26. National Institute of Public Health. (2007). Infectious diseases and poisonings in Poland. Annual Report Year 2007. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/epimeld/2007/Ch_2007. Accessed 25 Apr 2011.
  27. National Institute of Public Health. (2008). Infectious diseases and poisonings in Poland in 2008. Annual Report. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/epimeld/2008/Ch_2008. Accessed 25 Apr 2011.
  28. National Institute of Public Health. (2009). Infectious diseases and poisonings in Poland in 2009. Annual Report Year 2005. National Institute of Public Health. http://www.pzh.gov.pl/oldpage/epimeld/2009/Ch_2009. Accessed 25 Apr 2011.
  29. Ntezayabo, B., De Serres, G., & Duval, B. (2003). Pertussis resurgence in Canada largely caused by a cohort effect. Pediatric Infectious Disease Journal, 22, 22–27.PubMedCrossRefGoogle Scholar
  30. Paradowska-Stankiewicz, I., & Rudowska, J. (2010). Pertussis in Poland in 2008. Przegland Epidemiologiczny, 64, 181–183.PubMedGoogle Scholar
  31. Parkins, M. D., McNeil, S. A., & Laupland, K. B. (2009). Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention. Canadian Journal of Infectious Diseases & Medical Microbiology, 20, 81–90.Google Scholar
  32. Quinn, H. E., & McIntyre, P. B. (2007). Pertussis epidemiology in Australia over the decade 1995–2005 – Trends by region and age group. Communicable Diseases Intelligence, 31, 205–215.PubMedGoogle Scholar
  33. Rohani, P., Zhong, X., & King, A. A. (2010). Contact network structure explains the changing epidemiology of pertussis. Science, 12, 982–985.CrossRefGoogle Scholar
  34. Serres, G., Shadmani, R., Duval, B., Boulianne, N., Dery, P., Douville Fradet, M., Rochette, L., & Halperin, S. A. (2000). Morbidity of pertussis in adolescents and adults. Journal of Infectious Diseases, 181, 174–179.CrossRefGoogle Scholar
  35. Tan, T., Trindade, E., & Skowronski, D. (2005). Epidemiology of pertussis. Pediatric Infectious Disease Journal, 24, S10–S18.PubMedCrossRefGoogle Scholar
  36. Tanaka, M., Vitek, C. R., Pascual, F. B., Bisgard, K. M., Tate, J. E., & Murphy, T. V. (2003). Trends in pertussis among infants in the United States, 1980–1999. Journal of the American Medical Association, 290, 2968–2975.PubMedCrossRefGoogle Scholar
  37. Wendelboe, A. M., Njamkepo, E., Bourillon, A., Floret, D. D., Gaudelus, J., Gerber, M., Grimprel, E., Greenberg, D., Halperin, S., Liese, J., Munoz-Rivas, F., Teyssou, R., Guiso, N., & Van Rie, A. (2007). Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease, 26, 293–299.CrossRefGoogle Scholar
  38. WHO position paper. (2010). Pertussis vaccines. Weekly Epidemiological Record, 2010(40), 385–399.Google Scholar
  39. Wiese-Posselt, M., & Hellenbrand, W. (2010). Changes to the varicella and pertussis immunisation schedule in Germany 2009 background, rationale and implementation. Eurosurveillance, 15, pii: 19548.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Aneta Nitsch-Osuch
    • 1
  • Ernest Kuchar
    • 2
  • Grazyna Modrzejewska
    • 3
  • Iwona Pirogowicz
    • 4
  • Katarzyna Zycinska
    • 1
  • Kazimierz Wardyn
    • 1
  1. 1.Department of Family MedicineWarsaw Medical UniversityWarsawPoland
  2. 2.Department of Pediatric Infectious DiseasesWroclaw Medical UniversityWarsawPoland
  3. 3.WarsawPoland
  4. 4.Department of HygieneWroclaw Medical UniversityWarsawPoland

Personalised recommendations